Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Back

ESC Professional Premium Access

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor P. Haller (Boston, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Paul Michael Haller

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

6 more presentations in this session

Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

Speaker: Doctor F. Wenzl (Zurich, CH)

Access

Abstract

Slides

Prevalence of coronary atherosclerosis in individuals with pre-diabetes and diabetes compared to normoglycemic individuals

Speaker: Professor C. Ostgren (Linkoping, SE)

Access

Abstract

Slides

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Speaker: Doctor J. Li (Beijing, CN)

Access

Abstract

Slides

Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and mortality in type 1 diabetes

Speaker: Doctor H. Segersvard (Helsinki, FI)

Access

Abstract

Slides

Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

Speaker: Doctor D. Sa (Funchal, PT)

Access

Abstract

Slides

Access the full session

Coronary artery disease - Epidemiology, prognosis, outcome 5

Speakers: Doctor P. Haller, Doctor F. Wenzl, Professor C. Ostgren, Doctor J. Li, Doctor H. Segersvard...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources